Literature DB >> 16051078

[Ghosal haematodiaphyseal dysplasia: a new case].

C Vignon-Savoye1, M Le Merrer, A Vincens, M Monfort, P Talon.   

Abstract

Ghosal-type hematodiaphyseal dysplasia has been first described in 1986, as a steroid-dependent anemia with endosteal broadening of the long bone's diaphyses and metaphaphyses, which makes a distinction with the periosteal reaction in Camuratti-Engelmann's disease and with Caffey's disease. Extreme pallor is first noticed and leads to search for palpable thick long bones that are not always clinically obvious. The transmission of this rare entity seems to be autosomal recessive, with a common racial background from the Middle East and the Indian subcontinent. Anemia is considerably improved by steroids, which allow to avoid blood cells transfusions, but a minimum maintenance dose is necessary to keep the hemoglobin at a normal level probably during the whole life, involving iatrogen complications. The mechanism of anemia and the genetic cause of the disease are yet unknown.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051078     DOI: 10.1016/j.arcped.2005.01.026

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  4 in total

1.  Ghosal Syndrome--Ten Years Follow-up.

Authors:  Rakesh Mondal; Archan Sil; Shankha Subhra Nag; Tapas Sabui
Journal:  Indian J Pediatr       Date:  2015-01-20       Impact factor: 1.967

2.  Ghosal hematodiaphyseal dysplasia with myelofibrosis.

Authors:  Kalpana Datta; Madan Karmakar; Michael Hira; Sanjay Halder; Koushik Pramanik; Goutam Banerjee
Journal:  Indian J Pediatr       Date:  2012-09-15       Impact factor: 1.967

Review 3.  Ghosal hematodiaphyseal dysplasia-a concise review including an illustrative patient.

Authors:  Richa Arora; Shagun Aggarwal; Swaroopa Deme
Journal:  Skeletal Radiol       Date:  2014-08-30       Impact factor: 2.199

Review 4.  Ghosal type hemato-diaphyseal dysplasia: a rare variety of Engelmann's disease.

Authors:  R K Mondal; B Karmakar; P K Chandra; K Mukherjee
Journal:  Indian J Pediatr       Date:  2007-03       Impact factor: 5.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.